GTBP · GT Biopharma, Inc. · Insider Trading

The option vests in four equal quarterly installments beginning on January 1, 2026.

The option vests in four equal quarterly installments beginning on January 1, 2025.

The options are fully vested and exercisable.

The option vests in four equal quarterly installments beginning on January 1, 2025.

The options are fully vested and exercisable.

The options are fully vested and exercisable.

The option vests in four equal quarterly installments beginning on January 1, 2026.

The options are fully vested and exercisable.

1/36th of the shares vest on the monthly anniversary of June 3, 2024 until fully vested, subject to full acceleration in the event the reporting person is involuntarily terminated by the registrant without Cause (as defined in the reporting person's Employment Agreement dated June 7, 2024), resignation by the reporting person for Good Reason (as defined in the reporting person's Employment Agreement dated June 7, 2024), or in the event of a Change in Control (as defined in the registrant's 2022 Omnibus Incentive Plan).

The reporting person transferred the shares without consideration to Anarjay Concepts, Inc., a corporation wholly-owned by the reporting person.

The reporting person transferred the shares without consideration to Anarjay Concepts, Inc., a corporation wholly-owned by the reporting person.

1/12th of the shares vest on the monthly anniversary of May 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is not re-elected to the board of directors or is removed from the board of directors other than for misconduct.

1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is not re-elected to the board of directors or is removed from the board of directors other than for misconduct.

1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is not re-elected to the board of directors or is removed from the board of directors other than for misconduct.

1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is not re-elected to the board of directors or is removed from the board of directors other than for misconduct, and the reporting person is involuntarily terminated by the registrant.

1/12th of the shares vest on the monthly anniversary of January 1, 2023 until fully vested, subject to full acceleration in the event the reporting person is involuntarily terminated by the registrant.

66,666 shares on the date of grant, and 66,667 shares on each February 14, 2023 and 2024.

240,984 shares vest on the date of grant and 120,492 shares vest on January 13, 2023.

1/4th of the shares vest on the date of grant and on each of September 8, 2022, December 8, 2022 and March 8, 2023.

1/4th of the shares vest on the date of grant and on each of September 8, 2022, December 8, 2022 and March 8, 2023.

The reporting person transferred the shares without consideration to Anarjay Concepts, Inc., a corporation wholly-owned by the reporting person.

1/4th of the shares vest on the date of grant and on each of September 9, 2022, December 9, 2022 and March 9, 2023.

The reporting person transferred the shares without consideration to Anarjay Concepts, Inc., a corporation wholly-owned by the reporting person.

33% on the date of grant, 33% on 6/1/22 and 34% on 6/1/23, subject to continued service and subject to full acceleration immediately prior to the consummation of a change of control.

While the maturity date of the Debenture was September 7, 2019, the Registrant did not repay the Debenture on the maturity date and the Debenture remained outstanding until converted.

Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on January 13, 2021, 2022 and 2023.

Represents a grant of shares of restricted stock ("RSAs") in connection with the reporting person's services as a director. 1/3rd of the RSAs vest on November 11, 2020, 2021 and 2022. The reporting person resigned as a director on April 23, 2021.

1/3rd of the shares vest on February 16, 2021, 2022, and 2023.

Represents a grant of options in connection with the reporting person's services as a director. 13rd of the shares underlying the options vest on February 16, 2021, 2022 and 2023.

Represents a grant of shares of restricted stock ("RSAs"). 1/3rd of the RSAs vest on November 11 2020, 2021 and 2022.

1/3rd of the shares vest on February 16, 2021, 2022 and 2023.

1/3rd of the shares vest on February 16, 2021, 2022 and 2023.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020.

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 11, 2020.